miRNA Biomarker-Guided Immunosuppression Minimization for liver diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Oct 2026: Trial registered, NCT07862439

The trials

NCT07862439: Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE)

State
Not started
Phase
Phase 2
People
180 planned
Started
Jan 2027
Primary completion
Jan 2031
Arms
miRNA Biomarker-Guided Immunosuppression Minimization
Results
None posted
  1. 7 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.